Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion type Assertion NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_head.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion description "[We designed a neoadjuvant and adjuvant clinical trial comparing an irradiated, granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting, allogeneic PDAC vaccine (GVAX) given as a single agent or in combination with low-dose cyclophosphamide to deplete regulatory T cells (Treg) as a means to study how the TME is altered by immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion evidence source_evidence_literature NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion SIO_000772 24942756 NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion wasDerivedFrom befree-2016 NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.
- NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_assertion wasGeneratedBy ECO_0000203 NP1193563.RAo86Oc4ej9_IOjkx-CxpKTZVU4AlihGtF94IVDoY6Ia8130_provenance.